KURA Earnings

Quarterly EPS
$-0.63
Q3 2024
$-0.22
Q4 2024
$-0.66
Q1 2025
$-0.75
Q2 2025
$-0.85
Q3 2025
$-0.92
Q4 2025
$-0.83
Q1 2026
$-0.77
Q2 2026
Latest Revenue20.9M
Latest Net Income-68327000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.7720.9M-68327000+36.5%-2.7%
Q1 2026-$0.8318.3M-73333000+29.5%-25.8%
Q4 2025-$0.9217.3M-80999000-67.8%-318.2%
Q3 2025-$0.8520.8M-74116000-34.9%
Q2 2025-$0.7515.3M-66122000-27.1%
Q1 2025-$0.6614.1M-57429000-11.9%
Q4 2024-$0.2253.9M-19217000+60.0%
Q3 2024-$0.630-54404000-26.0%
Q2 2024-$0.590-50837000
Q1 2024-$0.590-49525000
Q4 2023-$0.550-42786000
Q3 2023-$0.500-38602000
Kura Oncology (KURA) — Earnings